Showing 13,501 - 13,520 results of 13,706 for search '(( 50 mean decrease ) OR ( 100 ((((we decrease) OR (teer decrease))) OR (a decrease)) ))', query time: 0.58s Refine Results
  1. 13501

    Functional characterization of <i>CsYAB5</i> in cucumber. by Shuangshuang Yan (798064)

    Published 2020
    “…Blue stars in panels N’–P’ indicate extra vascular bundles in <i>CsYAB5</i>-RNAi lines. Scale bars represent 100 μm in panels A–D; 2 cm in panels E–F, H, and J–K; 1 mm in panel L; 500 μm in panels M–P; and 200 μm in panels M’–P’. …”
  2. 13502

    Table_4_Exploring the additive effect of Ampelopsis grossedentata flavonoids and Tween 80 on feeding Nubian goats.XLSX by Junhong Zhu (13957638)

    Published 2024
    “…The control group (CON group) was provided with a basal diet, while the experimental groups received diets supplemented with various dietary additives for a duration of 100 days: either a basal diet supplemented with 25 mg/kg of monensin (MN group), a basal diet containing 2.0 g/kg of Ampelopsis grossedentata flavonoids (AGF group), or a basal diet containing 7.5 mL/kg of Tween 80 (TW group). …”
  3. 13503

    Table_6_Exploring the additive effect of Ampelopsis grossedentata flavonoids and Tween 80 on feeding Nubian goats.XLSX by Junhong Zhu (13957638)

    Published 2024
    “…The control group (CON group) was provided with a basal diet, while the experimental groups received diets supplemented with various dietary additives for a duration of 100 days: either a basal diet supplemented with 25 mg/kg of monensin (MN group), a basal diet containing 2.0 g/kg of Ampelopsis grossedentata flavonoids (AGF group), or a basal diet containing 7.5 mL/kg of Tween 80 (TW group). …”
  4. 13504

    Table_1_Exploring the additive effect of Ampelopsis grossedentata flavonoids and Tween 80 on feeding Nubian goats.XLSX by Junhong Zhu (13957638)

    Published 2024
    “…The control group (CON group) was provided with a basal diet, while the experimental groups received diets supplemented with various dietary additives for a duration of 100 days: either a basal diet supplemented with 25 mg/kg of monensin (MN group), a basal diet containing 2.0 g/kg of Ampelopsis grossedentata flavonoids (AGF group), or a basal diet containing 7.5 mL/kg of Tween 80 (TW group). …”
  5. 13505

    Table_3_Exploring the additive effect of Ampelopsis grossedentata flavonoids and Tween 80 on feeding Nubian goats.XLSX by Junhong Zhu (13957638)

    Published 2024
    “…The control group (CON group) was provided with a basal diet, while the experimental groups received diets supplemented with various dietary additives for a duration of 100 days: either a basal diet supplemented with 25 mg/kg of monensin (MN group), a basal diet containing 2.0 g/kg of Ampelopsis grossedentata flavonoids (AGF group), or a basal diet containing 7.5 mL/kg of Tween 80 (TW group). …”
  6. 13506

    Table_2_Exploring the additive effect of Ampelopsis grossedentata flavonoids and Tween 80 on feeding Nubian goats.XLSX by Junhong Zhu (13957638)

    Published 2024
    “…The control group (CON group) was provided with a basal diet, while the experimental groups received diets supplemented with various dietary additives for a duration of 100 days: either a basal diet supplemented with 25 mg/kg of monensin (MN group), a basal diet containing 2.0 g/kg of Ampelopsis grossedentata flavonoids (AGF group), or a basal diet containing 7.5 mL/kg of Tween 80 (TW group). …”
  7. 13507

    Table_5_Exploring the additive effect of Ampelopsis grossedentata flavonoids and Tween 80 on feeding Nubian goats.XLSX by Junhong Zhu (13957638)

    Published 2024
    “…The control group (CON group) was provided with a basal diet, while the experimental groups received diets supplemented with various dietary additives for a duration of 100 days: either a basal diet supplemented with 25 mg/kg of monensin (MN group), a basal diet containing 2.0 g/kg of Ampelopsis grossedentata flavonoids (AGF group), or a basal diet containing 7.5 mL/kg of Tween 80 (TW group). …”
  8. 13508

    Table_2_Global, regional, and national years lived with disability due to blindness and vision loss from 1990 to 2019: Findings from the Global Burden of Disease Study 2019.docx by Shasha Li (139491)

    Published 2022
    “…Purpose<p>This study aimed to provide a comprehensive assessment of burden estimates and the secular trend of blindness and vision loss, as measured by years lived with disability (YLDs), at the global, regional, and national levels.…”
  9. 13509

    Knockdown of <i>fhplk1</i> disrupts growth and cell proliferation in juvenile <i>Fasciola hepatica in vitro.</i> by Paul McCusker (634425)

    Published 2025
    “…<b>(C)</b> Mean # EdU<sup>+</sup> nuclei ±SEM significantly decreased after four weeks of <i>fhplk1</i> dsRNA treatments in juvenile <i>F. hepatica</i> (n ≥ 15 for each treatment; Mann-Whitney U test). …”
  10. 13510

    Data_Sheet_1_Secular Trends in the Incidence of and Mortality Due to Alzheimer’s Disease and Other Forms of Dementia in China From 1990 to 2019: An Age-Period-Cohort Study and Join... by Yongliang Gao (11381418)

    Published 2021
    “…</p>Results<p>The age-standardized incidence and mortality rates per 100,000 population were 103.83 (95% UI, 87.93–118.87) and 23.32 (95% UI, 5.66–61.31), respectively, for dementia in 2019. …”
  11. 13511

    DataSheet_2_Causal analysis between altered levels of interleukins and obstructive sleep apnea.pdf by Minhan Yi (417990)

    Published 2022
    “…</p>Results<p>Nine different interleukins—IL-1β, IL-2, IL-4, IL-6, IL-8, IL-12, IL-17, IL-18, and IL-23—were elevated in OSA compared with control to varying degrees, ranging from 0.82 to 100.14 pg/ml, and one interleukin, IL-10, was decreased by 0.77 pg/ml. …”
  12. 13512

    Image_3_Global, regional, and national years lived with disability due to blindness and vision loss from 1990 to 2019: Findings from the Global Burden of Disease Study 2019.TIF by Shasha Li (139491)

    Published 2022
    “…Purpose<p>This study aimed to provide a comprehensive assessment of burden estimates and the secular trend of blindness and vision loss, as measured by years lived with disability (YLDs), at the global, regional, and national levels.…”
  13. 13513

    Data_Sheet_2_Genomic Surveillance of Ceftriaxone-Resistant Escherichia coli in Western New York Suggests the Extended-Spectrum β-Lactamase blaCTX-M-27 Is Emerging on Distinct Plasm... by Heba H. Mostafa (3097494)

    Published 2020
    “…Isolates were collected from both inpatients and outpatients and from urine and sterile-sites over a 2 month period in 2017 or throughout the year, respectively. …”
  14. 13514

    DataSheet_1_Causal analysis between altered levels of interleukins and obstructive sleep apnea.pdf by Minhan Yi (417990)

    Published 2022
    “…</p>Results<p>Nine different interleukins—IL-1β, IL-2, IL-4, IL-6, IL-8, IL-12, IL-17, IL-18, and IL-23—were elevated in OSA compared with control to varying degrees, ranging from 0.82 to 100.14 pg/ml, and one interleukin, IL-10, was decreased by 0.77 pg/ml. …”
  15. 13515

    Image_2_Global, regional, and national years lived with disability due to blindness and vision loss from 1990 to 2019: Findings from the Global Burden of Disease Study 2019.TIF by Shasha Li (139491)

    Published 2022
    “…Purpose<p>This study aimed to provide a comprehensive assessment of burden estimates and the secular trend of blindness and vision loss, as measured by years lived with disability (YLDs), at the global, regional, and national levels.…”
  16. 13516

    Table_3_Global, regional, and national years lived with disability due to blindness and vision loss from 1990 to 2019: Findings from the Global Burden of Disease Study 2019.docx by Shasha Li (139491)

    Published 2022
    “…Purpose<p>This study aimed to provide a comprehensive assessment of burden estimates and the secular trend of blindness and vision loss, as measured by years lived with disability (YLDs), at the global, regional, and national levels.…”
  17. 13517

    Image_1_Global, regional, and national years lived with disability due to blindness and vision loss from 1990 to 2019: Findings from the Global Burden of Disease Study 2019.TIF by Shasha Li (139491)

    Published 2022
    “…Purpose<p>This study aimed to provide a comprehensive assessment of burden estimates and the secular trend of blindness and vision loss, as measured by years lived with disability (YLDs), at the global, regional, and national levels.…”
  18. 13518

    Data_Sheet_1_Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis.pdf by Sha Fu (445944)

    Published 2021
    “…The alterations in clinical and biochemical parameters before and after taking sacubitril-valsartan (generally 50–100 mg b.i.d) were investigated, and safety was also assessed. …”
  19. 13519

    Image_6_Global, regional, and national years lived with disability due to blindness and vision loss from 1990 to 2019: Findings from the Global Burden of Disease Study 2019.TIF by Shasha Li (139491)

    Published 2022
    “…Purpose<p>This study aimed to provide a comprehensive assessment of burden estimates and the secular trend of blindness and vision loss, as measured by years lived with disability (YLDs), at the global, regional, and national levels.…”
  20. 13520

    Data Sheet 1_Valve-in-valve transcatheter aortic valve replacement (TAVR) leads to lower device success compared to TAVR in native stenosis.pdf by Michael Paukovitsch (16428786)

    Published 2025
    “…</p>Methods<p>Outcomes of consecutive patients treated with ViV-TAVR (N = 100) at our tertiary heart center between 2014 and 2022 were compared to TAVR (N = 2216) in native valves.…”